Renin-angiotensin System Inhibitors in the COVID-19 Pandemic: Consequences of Antihypertensive Drugs

Ruilope Urioste, Luis MiguelTamargo, JuanRuiz Hurtado, Gema2020-07-072020-07-072020Ruilope Urioste, L. M., Tamargo, J., & Ruiz-Hurtado, G. (2020). Renin–angiotensin system inhibitors in the COVID-19 pandemic: Consequences of antihypertensive drugs. European Heart Journal, 41(22), 2067–2069. https://doi.org/10.1093/eurheartj/ehaa4870195-668X1522-9645http://hdl.handle.net/11268/9020engRenin-angiotensin System Inhibitors in the COVID-19 Pandemic: Consequences of Antihypertensive Drugsjournal article10.1093/eurheartj/ehaa487open accessHipertensiónMedicamentos cardiovascularesCOVID-19Enfermedad cardiovascularMedicamentoVirología